Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
21 - 30 out of 509Page size: 10
Sort by: Title
  1. Published

    A primer on metabolic memory: Why existing diabesity treatments fail

    Copur, S., Rossing, Peter, Afsar, B., Sag, A. A., Siriopol, D., Kuwabara, M., Ortiz, A. & Kanbay, M., 2021, In: Clinical Kidney Journal. 14, 3, p. 756-767 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  2. Published

    A urinary proteome-based classifier for the early detection of decline in glomerular filtration

    Pontillo, C., Jacobs, L., Staessen, J. A., Schanstra, J. P., Rossing, Peter, Heerspink, H. J. L., Siwy, J., Mullen, W., Vlahou, A., Mischak, H., Vanholder, R., Zürbig, P. & Jankowski, J., 1 Sep 2017, In: Nephrology, Dialysis, Transplantation. 32, 9, p. 1510-1516 7 p., gfw239.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics

    Jørgensen, P. G., Jensen, M. T., Mogelvang, R., von Scholten, B. J., Bech, J., Hansen, T. F., Galatius, S., Biering-Sørensen, Tor, Andersen, H. U., Vilsbøll, Tina, Rossing, Peter & Jensen, J. S., Sep 2016, In: Diabetes and Vascular Disease Research. 13, 5, p. 321-330 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial

    Laursen, J. C., Søndergaard-Heinrich, N., de Melo, J. M. L., Haddock, B., Rasmussen, I. K. B., Safavimanesh, F., Hansen, C. S., Størling, Joachim, Larsson, Henrik Bo Wiberg, Groop, P., Frimodt-Møller, M., Andersen, U. B. & Rossing, Peter, 2021, In: EClinicalMedicine. 37, 10 p., 100895.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes

    von Scholten, B. J., Reinhard, H., Hansen, T. W., Lindhardt, M., Petersen, C. L., Wiinberg, N., Hansen, Peter Riis, Parving, H., Jacobsen, P. K. & Rossing, Peter, 2015, In: Cardiovascular Diabetology. 14, 10, p. 1-10 10 p., 59.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled study

    Sivalingam, S., Wasehuus, V. S., Rotbain Curovic, V., Blond, Martin Bæk, Hansen, T. W., Persson, F. & Rossing, Peter, 2024, In: Diabetes, Obesity and Metabolism. 26, 1, p. 54-64 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

    Pollock, C., Stefánsson, B., Reyner, D., Rossing, Peter, Sjöström, C. D., Wheeler, D. C., Langkilde, A. M. & Heerspink, H. J. L., 2019, In: The Lancet Diabetes and Endocrinology. 7, 6, p. 429-441 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Aldosterone Blockade Added to Renin-Angiotensin System Blockade to Reduce Albuminuria: A Path for Improved Renoprotection?

    Rossing, Peter & Persson, F., 2018, In: American Journal of the Medical Sciences. 355, 5, p. 407-408

    Research output: Contribution to journal › Editorial › Research

  10. Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial

    Bornstein, S. R., de Zeeuw, D., Heerspink, H. J. L., Schulze, F., Cronin, L., Wenz, A., Tuttle, K. R., Hadjadj, S. & Rossing, Peter, 2024, (E-pub ahead of print) In: Diabetes, Obesity and Metabolism.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...51 Next

ID: 12937790